Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
6 Objections for an Ocean side Wedding - 2James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- 3FBI arrests Brian Cole Jr. in Jan. 6 pipe bomb investigation, ending 5-year hunt
- 4The most effective method to Keep up with Proficient Handshakes in a Computerized World
- 5Figure out How to Stay away from Normal Handshaking Missteps
- Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
- Artemis II crew take new photo of far side of the moon
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- Scientists reveal earliest evidence for shifting of Earth’s crust
- Discovering a true sense of harmony: Contemplation and Care Practices
- Must-See Attractions in France
- ‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
